Additionally, the oncoprotein SS18-SSX, a distinctive marker of synovial sarcoma, has been scrutinized by Chang et al., who identified that the self-association of its intrinsically disordered QPGY domain leads to LLPS, contributing to its oncogenic activity in synovial sarcoma 143. The gene discussed is SS18; the disease is synovial sarcoma.